ACUTE CORONARY SYNDROME
Clinical trials for ACUTE CORONARY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ACUTE CORONARY SYNDROME trials appear
Sign up with your email to follow new studies for ACUTE CORONARY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stomach bug treatment could stop dangerous bleeding in heart patients
Disease control Recruiting nowThis study aims to see if treating a common stomach infection can prevent dangerous gastrointestinal bleeding in heart attack patients who have received stents and must take blood-thinning medications. It will compare a new two-drug infection treatment against a standard stomach …
Matched conditions: ACUTE CORONARY SYNDROME
Phase: PHASE4 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
One pill, three drugs: new strategy aims to save lives after heart attacks
Disease control Recruiting nowThis study is testing if combining three standard heart medications into a single 'polypill' can help people recover better after a heart attack. The goal is to see if taking one pill instead of three improves how well patients stick to their medication, which could lower the ris…
Matched conditions: ACUTE CORONARY SYNDROME
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Heart treatment trial aims to reduce bleeding risk in elderly patients
Disease control Recruiting nowThis international study is testing whether using just one blood-thinning medication is as safe and effective as using two after a specific type of heart artery procedure. It focuses on patients aged 75 and older or those at high risk for bleeding. The goal is to find the best ba…
Matched conditions: ACUTE CORONARY SYNDROME
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Could one pill replace two after a heart attack?
Disease control Recruiting nowThis study is testing if a simpler medication plan is safe and effective for people who have had a heart attack and received a stent. After the procedure, participants will take just one strong blood thinner (ticagrelor) plus a low-dose anti-inflammatory drug (colchicine), instea…
Matched conditions: ACUTE CORONARY SYNDROME
Phase: PHASE4 • Sponsor: CHA University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Personalized heart pill aims to stop second heart attacks
Disease control Recruiting nowThis study tests whether the drug dalcetrapib can prevent future heart attacks and strokes in people who recently had a heart-related hospitalization. It enrolls 2,000 participants with a specific genetic profile (AA genotype) who are clinically stable after their recent cardiac …
Matched conditions: ACUTE CORONARY SYNDROME
Phase: PHASE3 • Sponsor: DalCor Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New test aims to Fine-Tune heart medication, reduce bleeding risk
Disease control Recruiting nowThis study is testing if a new risk score can help doctors decide the best time to reduce the intensity of blood-thinning therapy for patients who had a heart attack and received a stent. About 3,500 participants will be assigned to have their medication adjusted either after 1 m…
Matched conditions: ACUTE CORONARY SYNDROME
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New heart attack treatment aims to slash cholesterol fast
Disease control Recruiting nowThis study is testing if starting a cholesterol-lowering medication called inclisiran very early after a heart attack or severe chest pain (acute coronary syndrome) is safe and effective. About 300 hospitalized patients will receive either inclisiran or a placebo (dummy injection…
Matched conditions: ACUTE CORONARY SYNDROME
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Breakthrough heart stent trial: dissolving device aims to outperform metal
Disease control Recruiting nowThis study is testing a new type of heart stent called Freesolve, which is made of magnesium and dissolves over time. It is being compared to a standard, permanent metal drug-coated stent (Xience) in 1,859 patients with blocked heart arteries. The main goal is to see if the disso…
Matched conditions: ACUTE CORONARY SYNDROME
Phase: NA • Sponsor: Biotronik AG • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Race to save hearts: stents challenge bypass surgery in major trial
Disease control Recruiting nowThis study aims to find out if a less invasive procedure using stents (PCI) is as safe and effective as traditional open-heart bypass surgery (CABG) for people having a serious type of heart attack warning. It will enroll 1000 adults with multiple clogged heart arteries. Particip…
Matched conditions: ACUTE CORONARY SYNDROME
Phase: NA • Sponsor: American Heart of Poland • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Heart surgery Follow-Up: which blood thinner keeps grafts open?
Disease control Recruiting nowThis study aims to find out whether taking two blood-thinning medications (ticagrelor plus aspirin) works better than taking aspirin alone to keep bypass grafts open after heart surgery. It will follow 360 patients who recently had bypass surgery for a heart attack or unstable an…
Matched conditions: ACUTE CORONARY SYNDROME
Sponsor: University Hospital, Linkoeping • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Old drug, new hope: common antibiotic could shield TB patients from lifelong lung damage
Disease control Recruiting nowThis study is testing if adding a common antibiotic called doxycycline to standard tuberculosis (TB) treatment can protect patients' lungs and heart from long-term damage. It will involve 150 adults with active TB who have just started treatment. The goal is to see if this extra …
Matched conditions: ACUTE CORONARY SYNDROME
Phase: PHASE3 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Mar 05, 2026 14:00 UTC
-
New stomach pill aims to shield heart patients from dangerous bleeding
Disease control Recruiting nowThis study is testing if a newer type of stomach acid medicine (tegoprazan) is as good as a standard medicine (rabeprazole) at preventing serious stomach problems like ulcers and bleeding. It involves over 3,000 adults with heart disease who are taking long-term blood thinners, w…
Matched conditions: ACUTE CORONARY SYNDROME
Phase: PHASE4 • Sponsor: Duk-Woo Park, MD • Aim: Disease control
Last updated Mar 03, 2026 14:06 UTC
-
Tiny chest implant aims to warn of silent heart attacks
Diagnosis Recruiting nowThis study is testing how well an already FDA-approved implanted device works in real-world use. The device, called the Guardian, is placed under the skin and is designed to detect early signs of a heart attack and alert the patient. Researchers are enrolling 500 people who are a…
Matched conditions: ACUTE CORONARY SYNDROME
Sponsor: Angel Medical Systems • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC
-
Heart procedure showdown: new catheter challenges standard wire
Diagnosis Recruiting nowThis study compares two devices doctors use during heart stent procedures to measure blood flow blockages. Researchers want to see if a newer, easier-to-use pressure catheter works as well as the standard pressure wire at preventing future heart problems. About 2,500 patients wit…
Matched conditions: ACUTE CORONARY SYNDROME
Phase: PHASE4 • Sponsor: CoreAalst BV • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Magnetic heart scanner could revolutionize heart attack detection
Diagnosis Recruiting nowThis study is testing a new bedside device called CardiAQ MCG that uses magnetic fields to detect heart attacks and blocked arteries. Researchers will enroll 150 patients who are already scheduled for heart procedures to see if the device's readings match what doctors find during…
Matched conditions: ACUTE CORONARY SYNDROME
Sponsor: SB Technology, Inc. • Aim: Diagnosis
Last updated Mar 23, 2026 15:15 UTC
-
New scan aims to spot heart attacks faster and more accurately
Diagnosis Recruiting nowThis study is testing a new, non-invasive scanning method called magnetocardiography (MCG) to see if it can accurately detect and locate heart attacks. Researchers will enroll about 3,800 people, including healthy volunteers and patients with chest pain, to build a computer model…
Matched conditions: ACUTE CORONARY SYNDROME
Sponsor: Qilu Hospital of Shandong University • Aim: Diagnosis
Last updated Mar 16, 2026 15:24 UTC
-
Can online therapy calm heart attack fears?
Symptom relief Recruiting nowThis study is testing whether an online therapy program can help people who have had a heart attack manage their anxiety about their heart health. Researchers will compare an online cognitive behavioral therapy (CBT) program designed for this specific anxiety to a general online …
Matched conditions: ACUTE CORONARY SYNDROME
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Apr 01, 2026 23:11 UTC
-
Scientists probe why Women's hearts are different
Knowledge-focused Recruiting nowThis study aims to understand why heart disease develops differently in women and men, focusing on the roles of hormones and inflammation. Researchers will collect blood samples and survey 6000 patients with chest pain to analyze hormone levels and inflammatory markers. The goal …
Matched conditions: ACUTE CORONARY SYNDROME
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Scientists peer inside heart attack plaques to solve diagnostic puzzle
Knowledge-focused Recruiting nowThis study aims to improve how doctors identify the specific type of plaque that causes a heart attack. Researchers will compare high-resolution artery images taken during a standard procedure with a detailed analysis of tiny tissue samples removed from the blockage. The goal is …
Matched conditions: ACUTE CORONARY SYNDROME
Sponsor: Fujita Health University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Massive heart study tracks 11,000 patients to uncover treatment patterns
Knowledge-focused Recruiting nowThis study aims to better understand heart attacks and heart injuries by collecting detailed information from 11,000 patients. Researchers will observe which treatments patients receive and track their long-term health outcomes. The goal is to gather knowledge to potentially impr…
Matched conditions: ACUTE CORONARY SYNDROME
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC